ArticleScientific reports2016
Risk of recurrence of retinopathy of prematurity after initial intravitreal ranibizumab therapy.
Joyce J T Chan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this paperpooled ittrialcites it